Found: 18
Select item for more details and to access through your institution.
Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 9, p. 2013, doi. 10.3390/cells9092013
- By:
- Publication type:
- Article
Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 6, p. 1475, doi. 10.3390/cells9061475
- By:
- Publication type:
- Article
Targeting Mitochondrial Oxidative Phosphorylation Abrogated Irinotecan Resistance in NSCLC.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-33667-6
- By:
- Publication type:
- Article
Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress.
- Published in:
- Nature Communications, 2017, v. 8, n. 2, p. 14374, doi. 10.1038/ncomms14374
- By:
- Publication type:
- Article
Transglutaminase 2-Mediated p53 Depletion Promotes Angiogenesis by Increasing HIF-1α-p300 Binding in Renal Cell Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 14, p. 5042, doi. 10.3390/ijms21145042
- By:
- Publication type:
- Article
Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 5, p. 757, doi. 10.1007/s00432-014-1623-5
- By:
- Publication type:
- Article
Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 8, p. 1279, doi. 10.1007/s00432-013-1433-1
- By:
- Publication type:
- Article
Reply to Krupenko et al., Comment on "Lee et al. The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer Cancers 2020, 12 , 1382".
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2238, doi. 10.3390/cancers13092238
- By:
- Publication type:
- Article
Phosphorylation of OCT4 Serine 236 Inhibits Germ Cell Tumor Growth by Inducing Differentiation.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2601, doi. 10.3390/cancers12092601
- By:
- Publication type:
- Article
ATP Production Relies on Fatty Acid Oxidation Rather than Glycolysis in Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2477, doi. 10.3390/cancers12092477
- By:
- Publication type:
- Article
The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1382, doi. 10.3390/cancers12061382
- By:
- Publication type:
- Article
Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition.
- Published in:
- Cancers, 2018, v. 10, n. 11, p. 455, doi. 10.3390/cancers10110455
- By:
- Publication type:
- Article
Allosteric inhibition site of transglutaminase 2 is unveiled in the N terminus.
- Published in:
- Amino Acids, 2018, v. 50, n. 11, p. 1583, doi. 10.1007/s00726-018-2635-2
- By:
- Publication type:
- Article
Inter-molecular crosslinking activity is engendered by the dimeric form of transglutaminase 2.
- Published in:
- Amino Acids, 2017, v. 49, n. 3, p. 461, doi. 10.1007/s00726-016-2293-1
- By:
- Publication type:
- Article
Increased expression of transglutaminase 2 drives glycolytic metabolism in renal carcinoma cells.
- Published in:
- Amino Acids, 2014, v. 46, n. 6, p. 1527, doi. 10.1007/s00726-014-1714-2
- By:
- Publication type:
- Article
Divergent results induced by different types of septic shock in transglutaminase 2 knockout mice.
- Published in:
- Amino Acids, 2013, v. 44, n. 1, p. 189, doi. 10.1007/s00726-012-1412-x
- By:
- Publication type:
- Article
Oxoglutarate Carrier Inhibition Reduced Melanoma Growth and Invasion by Reducing ATP Production.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 11, p. 1128, doi. 10.3390/pharmaceutics12111128
- By:
- Publication type:
- Article
Design and Synthesis of a Novel 4-aryl-N-(2-alkoxythieno [2,3- b ]pyrazine-3-yl)-4-arylpiperazine-1-carboxamide DGG200064 Showed Therapeutic Effect on Colon Cancer through G2/M Arrest.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 5, p. 502, doi. 10.3390/ph15050502
- By:
- Publication type:
- Article